scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1083399519 |
P356 | DOI | 10.1186/S12885-017-3085-Z |
P932 | PMC publication ID | 5286817 |
P698 | PubMed publication ID | 28143426 |
P50 | author | Carsten Bokemeyer | Q1045499 |
Valentin Stonik | Q16702301 | ||
P2093 | author name string | Jessica Hauschild | |
Friedemann Honecker | |||
Udo Schumacher | |||
Alexandra S Silchenko | |||
Gunhild von Amsberg | |||
Katharina Otte | |||
Sergey A Avilov | |||
Vladimir I Kalinin | |||
Sergey A Dyshlovoy | |||
Ramin Madanchi | |||
Winfried H Alsdorf | |||
P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Q22676705 |
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 | ||
Sea Cucumbers Metabolites as Potent Anti-Cancer Agents | Q26863314 | ||
Integrative modelling of the influence of MAPK network on cancer cell fate decision | Q28534949 | ||
Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 | ||
Role of autophagy in cancer | Q29620348 | ||
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial | Q30277192 | ||
Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis | Q31137239 | ||
Recent advances in treatment of advanced urothelial carcinoma | Q33565845 | ||
Cell death independent of caspases: a review. | Q34415492 | ||
Caspase-independent cell death | Q34433759 | ||
Caspases and cancer: mechanisms of inactivation and new treatment modalities | Q35845523 | ||
Role of JNK activation in apoptosis: a double-edged sword | Q36027363 | ||
P53 as a prognostic marker for bladder cancer: a meta-analysis and review. | Q36243745 | ||
Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy | Q36442830 | ||
p53 mutations in urinary bladder cancer. | Q36622335 | ||
Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer | Q37049712 | ||
The dark side of a tumor suppressor: anti-apoptotic p53. | Q37115437 | ||
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment | Q37299613 | ||
Caspase-independent cell death: leaving the set without the final cut. | Q37310195 | ||
The role of autophagy in cancer: therapeutic implications | Q37924056 | ||
Anticancer activity of sea cucumber triterpene glycosides | Q38371933 | ||
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies. | Q38506739 | ||
Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature. | Q38593842 | ||
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. | Q38809660 | ||
Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells | Q38823364 | ||
Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization. | Q38861914 | ||
Quinone-carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: synthesis and determination of in vitro activity. | Q39015286 | ||
Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent | Q39033245 | ||
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity | Q39381372 | ||
Stress-activated kinase pathway alteration is a frequent event in bladder cancer | Q39431237 | ||
Properties of cell lines established from transitional cell cancers of the human urinary tract | Q39431463 | ||
In vitro cultivation of epithelial cells derived from tumors of the human urinary tract | Q42803065 | ||
Do inducers of apoptosis trigger caspase-independent cell death? | Q45267818 | ||
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer | Q46616369 | ||
Constituents of the sea cucumber Cucumaria okhotensis. Structures of okhotosides B1-B3 and cytotoxic activities of some glycosides from this species | Q80742409 | ||
Second-line chemotherapy for advanced urothelial cancer: because we should or because we can? | Q84420039 | ||
Frondoside A. A novel triterpene glycoside from the holothurian Cucumariafrondosa | Q105272945 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autophagy | Q288322 |
P304 | page(s) | 93 | |
P577 | publication date | 2017-02-01 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells | |
P478 | volume | 17 |